These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35565400)

  • 1. The Role of Hypofractionation in Proton Therapy.
    Santos A; Penfold S; Gorayski P; Le H
    Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is moderate hypofractionation accepted as a new standard of care in north america for prostate cancer patients treated with external beam radiotherapy? Survey of genitourinary expert radiation oncologists.
    McClelland S; Sandler KA; Degnin C; Chen Y; Hung AY; Mitin TE
    Int Braz J Urol; 2019; 45(2):273-287. PubMed ID: 30676300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998-2016.
    Beckmann K; Garmo H; Nilsson P; Franck Lissbrant I; Widmark A; Stattin P
    Acta Oncol; 2020 May; 59(5):549-557. PubMed ID: 32122185
    [No Abstract]   [Full Text] [Related]  

  • 4. Chest wall toxicity after hypofractionated proton beam therapy for liver malignancies.
    Yeung R; Bowen SR; Chapman TR; MacLennan GT; Apisarnthanarax S
    Pract Radiat Oncol; 2018; 8(4):287-293. PubMed ID: 29452863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
    Widmark A; Gunnlaugsson A; Beckman L; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Fransson P; Tavelin B; Norman D; Zackrisson B; Anderson H; Kjellén E; Franzén L; Nilsson P
    Lancet; 2019 Aug; 394(10196):385-395. PubMed ID: 31227373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Hypofractionated Radiation Therapy with Photons, Protons, and Heavy Ions for Treating Extracranial Lesions.
    Laine AM; Pompos A; Timmerman R; Jiang S; Story MD; Pistenmaa D; Choy H
    Front Oncol; 2015; 5():302. PubMed ID: 26793619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton beam radiotherapy for patients with early-stage and advanced lung cancer: a narrative review with contemporary clinical recommendations.
    Chiang JS; Yu NY; Daniels TB; Liu W; Schild SE; Sio TT
    J Thorac Dis; 2021 Feb; 13(2):1270-1285. PubMed ID: 33717598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofractionation for prostate cancer: an update.
    Tiberi D; Vavassis P; Nguyen D; Yassa M
    Expert Rev Endocrinol Metab; 2017 May; 12(3):199-205. PubMed ID: 30063454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overall Survival After Treatment of Localized Prostate Cancer With Proton Beam Therapy, External-Beam Photon Therapy, or Brachytherapy.
    Liu Y; Patel SA; Jani AB; Gillespie TW; Patel PR; Godette KD; Hershatter BW; Shelton JW; McDonald MW
    Clin Genitourin Cancer; 2021 Jun; 19(3):255-266.e7. PubMed ID: 32972877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The radiobiology of hypofractionation.
    Nahum AE
    Clin Oncol (R Coll Radiol); 2015 May; 27(5):260-9. PubMed ID: 25797579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofractionation for clinically localized prostate cancer.
    Hickey BE; James ML; Daly T; Soh FY; Jeffery M
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011462. PubMed ID: 31476800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group.
    Parzen JS; Hartsell W; Chang J; Apisarnthanarax S; Molitoris J; Durci M; Tsai H; Urbanic J; Ashman J; Vargas C; Stevens C; Kabolizadeh P
    Radiat Oncol; 2020 Nov; 15(1):255. PubMed ID: 33148296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated Radiotherapy for Localized Prostate Cancer: A Challenging Accelerated Hypofractionated Radiotherapy.
    Yamazaki H; Nakamura S; Suzuki G; Yoshida K; Yoshioka Y; Koizumi M; Ogawa K
    Anticancer Res; 2015 Oct; 35(10):5167-77. PubMed ID: 26408674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale, conduct, and outcome using hypofractionated radiotherapy in prostate cancer.
    Ritter M
    Semin Radiat Oncol; 2008 Oct; 18(4):249-56. PubMed ID: 18725112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of hypofractionated radiotherapy for prostate cancer.
    Spyropoulou D; Kardamakis D
    ISRN Oncol; 2012; 2012():410892. PubMed ID: 22934194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton RBE dependence on dose in the setting of hypofractionation.
    Friedrich T
    Br J Radiol; 2020 Mar; 93(1107):20190291. PubMed ID: 31437004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbon Ion Radiotherapy in the Management of Hepatocellular Carcinoma.
    Abousaida B; Seneviratne D; Hoppe BS; Ko SJ; Asaithamby A; Cucinotta FA; Kirwan JM; Mody K; Toskich B; Ashman JB; Hallemeier CL; Krishnan S
    J Hepatocell Carcinoma; 2021; 8():1169-1179. PubMed ID: 34595139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated radiotherapy for prostate cancer in the postoperative setting: What is the evidence so far?
    Picardi C; Perret I; Miralbell R; Zilli T
    Cancer Treat Rev; 2018 Jan; 62():91-96. PubMed ID: 29178983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of dynamic adaptive passive scattering proton therapy with computed tomography image guidance in the lung.
    Moriya S; Tachibana H; Hotta K; Nakamura N; Sakae T; Akimoto T
    Med Phys; 2017 Sep; 44(9):4474-4481. PubMed ID: 28665491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.